• Home
  • Events
  • Monday Lunch Live with Dr David Gyorki and Dr Stephen Wong
Back to all events
18 Nov 2019
  • Peter MacCallum Cancer Centre
  • Victorian Comprehensive Cancer Centre
  • Peter Doherty Institute for Infection and Immunity
1-2pm

Monday Lunch Live with Dr David Gyorki and Dr Stephen Wong

Understanding the dormant danger of melanoma metastasis - collaboration across VCCC partners to explore a fundamental question in melanoma immunology.

The presentation will acknowledge National Skin Cancer Action Week with a review of melanoma research in the VCCC alliance and the role of Melanoma Research Victoria.

The presentation will acknowledge National Skin Cancer Action Week with a review of melanoma research in the VCCC alliance and the role of Melanoma Research Victoria. Hear the progress made by Dr Gyorki with Associate Professor Thomas Gebhardt, Peter Doherty Institute on micrometastasis and dormancy. Dr Stephen Wong, Peter MacCallum Cancer Centre will also talk about the impact on melanoma patient management through liquid biopsies.

 

Dr David Gyorki

Dr David Gyorki
VCCC Research and Education Lead, Melanoma and Skin Cancers

In his position as VCCC Research and Education Lead, Dr Gyorki brings together multiple disciplines, organisations and perspectives to produce solid outcomes in melanoma and high priority non-melanoma skin cancer.

Dr Gyorki completed his education and training at the University of Melbourne and St Vincent’s Hospital, during this time he also gained an MD degree at the Walter and Eliza Hall Institute. In addition, he has completed a clinical fellowship in complex surgical oncology at Memorial Sloan Kettering Cancer Center. Dr Gyorki previously held the Herman Fellowship in Clinical Cancer Research at the University of Melbourne and currently holds a Peter MacCallum Clinician Researcher Fellowship.

 

Dr Stephen Wong
Researcher, Peter MacCallum Cancer Centre

Dr Stephen Wong is a senior medical scientist and postdoctoral researcher who specialises in cancer genomics and molecular diagnostics at the Peter MacCallum Cancer Centre. His research focuses on identifying and characterising novel molecular biomarkers in melanoma and in other malignancies.


 Can't attend in person? Register for Webinar